The move follows criticism from federal lawmakers and advocacy groups.
Eli Lilly will cut the price of its most commonly prescribed insulin products by 70% and expand a program that caps patient costs at $35 per month, the company said on Wednesday.
"The aggressive price cuts we're announcing today should make a real difference for Americans with diabetes," he added.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Eli Lilly to cut insulin prices by 70%, cap monthly costs at $35The price reductions for the life-saving medication come amid criticism that unaffordable insulin may constitute a human rights abuse.
Les mer »
Eli Lilly to cut insulin prices by 70 percentPharmaceutical giant Eli Lilly is slashing prices of commonly prescribed insulin drugs by 70 percent while capping related out-of-pocket costs at $35 a month, a move that should help address long-standing concerns about the high cost of diabetes care.
Les mer »
Under pressure, Eli Lilly cuts insulin prices 70%NEW: Eli Lilly is slashing the prices of its most-prescribed insulins amid pressure from consumers and the Biden administration. People with diabetes would see 70% reductions on its most common versions between now and the end of the year.
Les mer »
Eli Lilly cuts insulin prices up to 70% amid pressure to slash costsEli Lilly will cut the price of its most commonly prescribed insulin products by 70% and expand a program that caps patient costs at $35 per month, the company said on Wednesday. MORE ⬇️
Les mer »
Eli Lilly cuts insulin prices up to 70% amid pressure to slash costsCORRECTION: Eli Lilly will cut the price of its most commonly prescribed insulin products by 70% and expand a program that caps patient costs at $35 per month, the company says.
Les mer »